Correlation Between SAB Biotherapeutics and Revelation Biosciences

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and Revelation Biosciences, you can compare the effects of market volatilities on SAB Biotherapeutics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Revelation Biosciences.

Diversification Opportunities for SAB Biotherapeutics and Revelation Biosciences

-0.37

Correlation Coefficient

SAB Biotherapeutics  Revelation Biosciences

Very good diversification

The 3 months correlation between SAB and Revelation is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Revelation Biosciences go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Revelation Biosciences

Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 1.88 times less return on investment than Revelation Biosciences. In addition to that, SAB Biotherapeutics is 1.45 times more volatile than Revelation Biosciences. It trades about 0.04 of its total potential returns per unit of risk. Revelation Biosciences is currently generating about 0.12 per unit of volatility. If you would invest  0.68  in Revelation Biosciences on December 29, 2024 and sell it today you would earn a total of  0.50  from holding Revelation Biosciences or generate 73.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	94.83%
Values	Daily Returns

SAB Biotherapeutics  vs.  Revelation Biosciences

SAB Biotherapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, SAB Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Revelation Biosciences

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Revelation Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Revelation Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with SAB Biotherapeutics and Revelation Biosciences

The main advantage of trading using opposite SAB Biotherapeutics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.

The idea behind SAB Biotherapeutics and Revelation Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.